AX1 Stock Overview
Operates as a medical technology and health management company in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AX1 from our risk checks.
Sipai Health Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.69 |
| 52 Week High | HK$1.01 |
| 52 Week Low | HK$0.59 |
| Beta | 0 |
| 11 Month Change | 2.99% |
| 3 Month Change | 0.73% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -18.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| AX1 | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 0.7% | 0.7% | 0.008% |
| 1Y | n/a | -39.1% | 3.1% |
Return vs Industry: Insufficient data to determine how AX1 performed against the German Consumer Retailing industry.
Return vs Market: Insufficient data to determine how AX1 performed against the German Market.
Price Volatility
| AX1 volatility | |
|---|---|
| AX1 Average Weekly Movement | 6.5% |
| Consumer Retailing Industry Average Movement | 5.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: AX1 has not had significant price volatility in the past 3 months.
Volatility Over Time: AX1's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3,089 | Xuguang Ma | www.medbankshealthtech.com |
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People’s Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors.
Sipai Health Technology Co., Ltd. Fundamentals Summary
| AX1 fundamental statistics | |
|---|---|
| Market cap | €552.59m |
| Earnings (TTM) | -€32.84m |
| Revenue (TTM) | €605.11m |
0.9x
P/S Ratio-16.8x
P/E RatioIs AX1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AX1 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.71b |
| Cost of Revenue | CN¥4.30b |
| Gross Profit | CN¥412.45m |
| Other Expenses | CN¥668.22m |
| Earnings | -CN¥255.77m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 8.75% |
| Net Profit Margin | -5.43% |
| Debt/Equity Ratio | 0.1% |
How did AX1 perform over the long term?
See historical performance and comparison